March 20, 2020. COVID-19: Considerations for tuberculosis (TB) care services As the world comes together to tackle the COVID-19 pandemic, it is important to ensure that essential services and operations for dealing with long-standing...
Coronavirus infection COVID-19 (from the COrona VIrus Disease 2019) is a potentially fatal acute respiratory infection caused by severe acute respiratory syndrome 2 virus (SARS-CoV-2). Currently, the assessment of risk factors associated with...
Annual Epidemiological Report on TB in Europe On February 24, 2020, the European Center for Disease Prevention and Control (ECDC) published an annual report on tuberculosis in Europe. The analysis was based on data for 2017 retrieved from...
On February 14, 2020, Centers for Disease Control and Prevention (CDC) presented new guidelines for the treatment of latent tuberculosis infection (LTBI) developed by CDC and the National Tuberculosis Controllers Association (NTCA) [1]. The...
Incure has submitted 5 applications for the inclusion of 5 different additional formulation into EML and EMLc. Injectable Rifampicin, injectable isoniazid, injectable Ethambutol, injectable PAS are proposed for the inclusion into core list of EML...
In early 2019, consolidated drug-resistant TB treatment guidelines, complemented by a new edition of WHO’s Companion handbook for the programmatic management of drug-resistant tuberculosis will be released. According to new WHO...
On the road to success, the rule is always to look ahead. May you reach your destination and may your journey be wonderful. INCURE team wishes you a Happy New Year with the hope that you will have many blessings in the year to come. ...
December 3, 2018 – Global funding for tuberculosis (TB) research climbed to a previously unreported high of USD $772 million in 2017, according to a report released today by Treatment Action Group (TAG) and the United Nations-hosted Stop TB...
The most important conference on tuberculosis was held on 24-27 october 2018 in the Hague, Netherlands Her Imperial Highness Princess Akishino of Japan, and Her Royal Highness Princess Margriet of The Netherlands joined the Inaugural Session...
The first ever United Nations High-Level Meeting (UN HLM) on tuberculosis was held in New York, 26 September 2018 because urgent action at the highest political level is needed if global goals to end TB are to be achieved. ...
Tuberculosis (TB) is one of the top 10 causes of death worldwide. In 2016, 10.4 million people fell ill with TB, and 1.7 million died from the disease (including 0.4 million among people with HIV). Over 95% of TB deaths occur in low- and...
http://www.europeanlung.org/en/news-and-events/news/interview-with-incure ...
Recorded live broadcast How to overcome tuberculosis in Ukraine? Interview with the representative of Ukraine at the UN consultations. Interview with Tatyana Spynsian, vice director of «COMMUNICABLE DISEASES INTENSIVE CARE...
The interactive hearing was held in the UN headquarters (New York City), on June 4th. As part of the preparatory process for the high-level meeting, the President of the General Assembly, with the support of the World Health Organization and...
With the support of INCURE, a methodical training was conducted for the TB services in the Kharkivska oblast. Professor Dmitry Butov made a presentation in which he showed the world dynamics of the fight against tuberculosis, as well as the...
A unique platform that resulted in a promising HIV vaccine has also led to a new, highly effective vaccine against tuberculosis that is moving toward testing in humans. The new vaccine completely protected 41 percent and reduced overall TB disease...
On March 27, within the framework of World TB Day, with the support of INCURE, a press conference was held in UNIAN on the topic: "Accelerating on the way to tuberculosis elimination in Ukraine". The head of multidrug-resistant tuberculosis...
INCURE team organizes a press conference "Accelerating on the path of tuberculosis elimination in Ukraine" on the occasion of World TB Day On March 27, at 11:30, within the framework of the World TB Day, UNIAN will host a press conference on...
A recent research has been published on Science Translational Medicine. As scientists report, accurate detection of live Mycobacterium tuberculosis (Mtb) could improve TB diagnosis and patient treatment. Carolyn Bertozzi from Stanford University...
INCURE participated in methodological training for TB specialists, which was given within the annual meeting on the results of TB program in Chernivtsi oblast. More than 60 specialists from Chernivtsi oblast had an opprtunity to update their...
The presentation is currently available only in ukrainian: /userfiles/files/severe%20tb.ppsx ...
The 48th edition of the most important conference dedicated to TB epidemic was held in Mexico on 11 to 14 October 2017. The Union president joined INCURE side session! Delegates from more than 100 countries, among which healthcare specialists,...
The largest meeting on respiratory medicine was held in Milan (Italy) from 9 to 13 of September 2017. Healthcare specialists, scientists, clinicians participated on the congress providing and deepening their knowledge with 18 000 colleagues from...
Within the framework of Union Africa conference a Side-meeting was organized, where TB specialists (UNION, INCURE, WHO, GDF and national chief TB specialists) from different countries discussed with INCURE about severely ill TB patients. As the...
The conference was held in Accra (Ghana) from 10 – 13 July 2017 and it gathered more than 900 delegates from 54 countries. The main focus was given to tuberculosis (TB) and co-morbidities, data management for TB control; multidrug-resistant TB,...
INCURE became a part of the biggest Scientific Conference on Lung Health in Kenya 20-23rd June 2017. Executive Director of INCURE, Dr. Alex Denisov made a presentation “SEVERELY ILL TB PATIENTS: ARE THERE ADDITIONAL POSSIBILITIES TO SAVE...
You are free to download, share and transmit this poster. You may not alter, transform or build upon this work. /userfiles/files/poster.pdf ...
In the world there is a high incidence of TB among children. Tentatively assumed that each year 500,000 children develop TB, but it is recognized that this data is hypothetical. It is generally believed that among the new TB cases the disease can...
One of the main objectives of the symposium was to alert specialists about new opportunities for anti-TB treatment in Romania due to the emergence of new forms of long-used drugs (first-line intravenous anti-tuberculosis drugs and Isoniazid-syrup for...
28th October-1st November INCURE participated in the work of The Union World Conference on Lung Health in Barcelona (Spain). It is the largest specialized conference, dedicated to one of the most dangerous communicable diseases - tuberculosis...
EXPLAIN TB - is a free application for iPhone and Android, that allows doctors easily explain to a TB patient details about the TB disease and the need for therapy. The application is translated into many languages, to improve access to information...
6-10 September INCURE participated in the work of annual congress ERS-2014 in Munich (Germany). More than 100 people from Italy, Germany, India, Kenya, Romania, Republic of Moldova, Algeria, Iran and other countries became the new members of...
